FDA Approved: TYKERB — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA's Original Application page documents the original FDA approval of TYKERB (lapatinib) for HER2-overexpressing breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tykerb (lapatinib)

Snippet

ORIG AP for TYKERB (LAPATINIB)